Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5)
Forero-Torres, Andres, Shah, Jatin, Wood, Tina, Posey, James, Carlisle, Ronda, Copigneaux, Catherine, Luo, Feng Roger, Wojtowicz-Praga, Slawomir, Percent, Ivor, Saleh, Mansoor
Published in Cancer biotherapy & radiopharmaceuticals (01.02.2010)
Published in Cancer biotherapy & radiopharmaceuticals (01.02.2010)
Get full text
Journal Article
Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models
Kulukian, Anita, Lee, Patrice, Taylor, Janelle, Rosler, Robert, de Vries, Peter, Watson, Daniel, Forero-Torres, Andres, Peterson, Scott
Published in Molecular cancer therapeutics (01.04.2020)
Published in Molecular cancer therapeutics (01.04.2020)
Get full text
Journal Article
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Dirix, Luc Y., Takacs, Istvan, Jerusalem, Guy, Nikolinakos, Petros, Arkenau, Hendrik-Tobias, Forero-Torres, Andres, Boccia, Ralph, Lippman, Marc E., Somer, Robert, Smakal, Martin, Emens, Leisha A., Hrinczenko, Borys, Edenfield, William, Gurtler, Jayne, von Heydebreck, Anja, Grote, Hans Juergen, Chin, Kevin, Hamilton, Erika P.
Published in Breast cancer research and treatment (01.02.2018)
Published in Breast cancer research and treatment (01.02.2018)
Get full text
Journal Article
Web Resource
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Younes, Anas, Bartlett, Nancy L, Leonard, John P, Kennedy, Dana A, Lynch, Carmel M, Sievers, Eric L, Forero-Torres, Andres
Published in The New England journal of medicine (04.11.2010)
Published in The New England journal of medicine (04.11.2010)
Get full text
Journal Article
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Bartlett, Nancy L., Herrera, Alex F., Domingo-Domenech, Eva, Mehta, Amitkumar, Forero-Torres, Andres, Garcia-Sanz, Ramon, Armand, Philippe, Devata, Sumana, Izquierdo, Antonia Rodriguez, Lossos, Izidore S., Reeder, Craig, Sher, Taimur, Chen, Robert, Schwarz, Sylvia E., Alland, Leila, Strassz, Andras, Prier, Kim, Choe-Juliak, Cassandra, Ansell, Stephen M.
Published in Blood (19.11.2020)
Published in Blood (19.11.2020)
Get full text
Journal Article
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
Horwitz, Steven, O'Connor, Owen A, Advani, Ranjana, Rossi, Giuseppe, Kim, Won Seog, Illés, Árpád, Tobinai, Kensei, Yeh, Su-Peng, Shustov, Andrei, Yuen, Sam, Iyer, Swaminathan, Hua, Zhaowei, Little, Meredith, Rao, Shangbang, Woolery, Joseph, Manley, Thomas, Aboulafia, David, Bartlett, Nancy, Belada, David, Yehuda, Dina Ben, Benedetti, Fabio, Bordessoule, Dominique, Chang, Hung, Cheong, June Weon, Choi, Ilseung, Colita, Andrei, Congui, Angela Giovanna, Dang, Nam, Davison, Kelly, de Guibert, Sophie, Delwail, Vincent, di Raimondo, Francesco, Do, Young Rok, Domingo, Eva, Douvas, Michael, Dreyling, Martin, Fay, Keith, Ferrero, Silvia Fernandez, Flinn, Ian Winchester, Forero-Torres, Andres, Friedberg, Jonathan, Fukuhara, Noriko, Garcia-Marco, Jose, Cruz, Jorge Gayoso, Gurion, Ronit, Christensen, Jacob Haaber, Hajek, Roman, Hatake, Kiyohiko, Horowitz, Netanel, Illes, Arpad, Illidge, Tim, Ishizawa, Kenichi, Islas-Ohlmayer, Miguel, Jacobsen, Eric, Janakiram, Murali, Jurczak, Wojciech, Kaminski, Mark, Kato, Koji, Kim, Won Seog, Iyer, Swaminathan, Kuo, Ching-Yuan, Lazaroiu, Mihaela Cornelia, Lee, Jong-Seok, Lennard, Anne, LaRosee, Paul, Levi, Itai, Link, Brian, Maisonneuve, Herve, Maruyama, Dai, Mayer, Jiri, Mocikova, Heidi, Morra, Enrica, Morschhauser, Franck, Munoz, Javier, Nagai, Hirokazu, Opat, Stephen, Pettengell, Ruth, Pezzutto, Antonio, Pfreundschuh, Michael, Pro, Barbara, Reyes, Ruben, Izquierdo, Antonia Rodriguez, Rossi, Giuseppe, Ruan, Jia, Salles, Gilles, Sarriera, Jose, Shibayama, Hirohiko, Shustov, Andrei, Suh, Cheolwon, Sureda, Anna, Tanimoto, Mitsune, Taniwaki, Masafumi, Tilly, Herve, Tsukamoto, Norifumi, Wilhelm, Martin, Yamamoto, Kazuhito, Yeh, Su-Peng, Yun, Hwan Jung, Zain, Jasmine, Zinzani, Pier Luigi
Published in The Lancet (British edition) (19.01.2019)
Published in The Lancet (British edition) (19.01.2019)
Get full text
Journal Article
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein
Forero-Torres, Andres, Shen, Sui, Breitz, Hazel, Sims, Robert B, Axworthy, Don B, Khazaeli, M B, Chen, Kuang-Ho, Percent, Ivor, Besh, Stephen, LoBuglio, Albert F, Meredith, Ruby F
Published in Cancer biotherapy & radiopharmaceuticals (01.08.2005)
Published in Cancer biotherapy & radiopharmaceuticals (01.08.2005)
Get full text
Journal Article
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma
LaCasce, Ann S., Bociek, R. Gregory, Sawas, Ahmed, Caimi, Paolo, Agura, Edward, Matous, Jeffrey, Ansell, Stephen M., Crosswell, Howland E., Islas-Ohlmayer, Miguel, Behler, Caroline, Cheung, Eric, Forero-Torres, Andres, Vose, Julie, O'Connor, Owen A., Josephson, Neil, Wang, Yinghui, Advani, Ranjana
Published in Blood (05.07.2018)
Published in Blood (05.07.2018)
Get full text
Journal Article
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
Pusztai, Lajos, Yau, Christina, Wolf, Denise M., Han, Hyo S., Du, Lili, Wallace, Anne M., String-Reasor, Erica, Boughey, Judy C., Chien, A. Jo, Elias, Anthony D., Beckwith, Heather, Nanda, Rita, Albain, Kathy S., Clark, Amy S., Kemmer, Kathleen, Kalinsky, Kevin, Isaacs, Claudine, Thomas, Alexandra, Shatsky, Rebecca, Helsten, Theresa L., Forero-Torres, Andres, Liu, Minetta C., Brown-Swigart, Lamorna, Petricoin, Emmanuel F., Wulfkuhle, Julia D., Asare, Smita M., Wilson, Amy, Singhrao, Ruby, Sit, Laura, Hirst, Gillian L., Berry, Scott, Sanil, Ashish, Asare, Adam L., Matthews, Jeffrey B., Perlmutter, Jane, Melisko, Michelle, Rugo, Hope S., Schwab, Richard B., Symmans, W. Fraser, Yee, Doug, van’t Veer, Laura J., Hylton, Nola M., DeMichele, Angela M., Berry, Donald A., Esserman, Laura J.
Published in Cancer cell (12.07.2021)
Published in Cancer cell (12.07.2021)
Get full text
Journal Article
Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies
Forero-Torres, Andres, Ramchandren, Radhakrishnan, Yacoub, Abdulraheem, Wertheim, Michael S., Edenfield, William J., Caimi, Paolo, Gutierrez, Martin, Akard, Luke, Escobar, Carolina, Call, Justin, Persky, Daniel, Iyer, Swaminathan, DeMarini, Douglas J., Zhou, Li, Chen, Xuejun, Dawkins, Fitzroy, Phillips, Tycel J.
Published in Blood (18.04.2019)
Published in Blood (18.04.2019)
Get full text
Journal Article
Ultrasound Imaging of Breast Tumor Perfusion and Neovascular Morphology
Hoyt, Kenneth, Umphrey, Heidi, Lockhart, Mark, Robbin, Michelle, Forero-Torres, Andres
Published in Ultrasound in medicine & biology (01.09.2015)
Published in Ultrasound in medicine & biology (01.09.2015)
Get full text
Journal Article
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
Nanda, Rita, Liu, Minetta C, Yau, Christina, Shatsky, Rebecca, Pusztai, Lajos, Wallace, Anne, Chien, A Jo, Forero-Torres, Andres, Ellis, Erin, Han, Heather, Clark, Amy, Albain, Kathy, Boughey, Judy C, Jaskowiak, Nora T, Elias, Anthony, Isaacs, Claudine, Kemmer, Kathleen, Helsten, Teresa, Majure, Melanie, Stringer-Reasor, Erica, Parker, Catherine, Lee, Marie C, Haddad, Tufia, Cohen, Ronald N, Asare, Smita, Wilson, Amy, Hirst, Gillian L, Singhrao, Ruby, Steeg, Katherine, Asare, Adam, Matthews, Jeffrey B, Berry, Scott, Sanil, Ashish, Schwab, Richard, Symmans, W Fraser, van 't Veer, Laura, Yee, Douglas, DeMichele, Angela, Hylton, Nola M, Melisko, Michelle, Perlmutter, Jane, Rugo, Hope S, Berry, Donald A, Esserman, Laura J
Published in JAMA oncology (01.05.2020)
Published in JAMA oncology (01.05.2020)
Get more information
Journal Article
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
YOUNES, Anas, GOPAL, Ajay K, FORERO-TORRES, Andres, MOSKOWITZ, Craig H, CONNORS, Joseph M, ENGERT, Andreas, LARSEN, Emily K, KENNEDY, Dana A, SIEVERS, Eric L, CHEN, Robert, SMITH, Scott E, ANSELL, Stephen M, ROSENBLATT, Joseph D, SAVAGE, Kerry J, RAMCHANDREN, Radhakrishnan, BARTLETT, Nancy L, CHESON, Bruce D, DE VOS, Sven
Published in Journal of clinical oncology (20.06.2012)
Published in Journal of clinical oncology (20.06.2012)
Get full text
Journal Article
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
Tolaney, Sara M, Tayob, Nabihah, Dang, Chau, Yardley, Denise A, Isakoff, Steven J, Valero, Vicente, Faggen, Meredith, Mulvey, Therese, Bose, Ron, Hu, Jiani, Weckstein, Douglas, Wolff, Antonio C, Reeder-Hayes, Katherine, Rugo, Hope S, Ramaswamy, Bhuvaneswari, Zuckerman, Dan, Hart, Lowell, Gadi, Vijayakrishna K, Constantine, Michael, Cheng, Kit, Briccetti, Frederick, Schneider, Bryan, Garrett, Audrey Merrill, Marcom, Kelly, Albain, Kathy, DeFusco, Patricia, Tung, Nadine, Ardman, Blair, Nanda, Rita, Jankowitz, Rachel C, Rimawi, Mothaffar, Abramson, Vandana, Pohlmann, Paula R, Van Poznak, Catherine, Forero-Torres, Andres, Liu, Minetta, Ruddy, Kathryn, Zheng, Yue, Rosenberg, Shoshana M, Gelber, Richard D, Trippa, Lorenzo, Barry, William, DeMeo, Michelle, Burstein, Harold, Partridge, Ann, Winer, Eric P, Krop, Ian
Published in Journal of clinical oncology (20.07.2021)
Published in Journal of clinical oncology (20.07.2021)
Get full text
Journal Article
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study
Straus, David J., Długosz-Danecka, Monika, Alekseev, Sergey, Illés, Árpád, Picardi, Marco, Lech-Maranda, Ewa, Feldman, Tatyana, Smolewski, Piotr, Savage, Kerry J., Bartlett, Nancy L., Walewski, Jan, Ramchandren, Radhakrishnan, Zinzani, Pier Luigi, Hutchings, Martin, Connors, Joseph M., Radford, John, Munoz, Javier, Kim, Won Seog, Advani, Ranjana, Ansell, Stephen M., Younes, Anas, Miao, Harry, Liu, Rachael, Fenton, Keenan, Forero-Torres, Andres, Gallamini, Andrea
Published in Blood (05.03.2020)
Published in Blood (05.03.2020)
Get full text
Journal Article
Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study
Fanale, Michelle A, Horwitz, Steven M, Forero-Torres, Andres, Bartlett, Nancy L, Advani, Ranjana H, Pro, Barbara, Chen, Robert W, Davies, Andrew, Illidge, Tim, Huebner, Dirk, Kennedy, Dana A, Shustov, Andrei R
Published in Journal of clinical oncology (01.10.2014)
Published in Journal of clinical oncology (01.10.2014)
Get full text
Journal Article
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma
Phillips, Tycel J., Forero-Torres, Andres, Sher, Taimur, Diefenbach, Catherine S., Johnston, Patrick, Talpaz, Moshe, Pulini, Jennifer, Zhou, Li, Scherle, Peggy, Chen, Xuejun, Barr, Paul M.
Published in Blood (19.07.2018)
Published in Blood (19.07.2018)
Get full text
Journal Article
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL
Friedberg, Jonathan W., Forero-Torres, Andres, Bordoni, Rodolfo E., Cline, Vivian J.M., Patel Donnelly, Dipti, Flynn, Patrick J., Olsen, Gregg, Chen, Robert, Fong, Abraham, Wang, Yinghui, Yasenchak, Christopher A.
Published in Blood (28.12.2017)
Published in Blood (28.12.2017)
Get full text
Journal Article
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy
Magbanua, Mark Jesus M., Brown Swigart, Lamorna, Ahmed, Ziad, Sayaman, Rosalyn W., Renner, Derrick, Kalashnikova, Ekaterina, Hirst, Gillian L., Yau, Christina, Wolf, Denise M., Li, Wen, Delson, Amy L., Asare, Smita, Liu, Minetta C., Albain, Kathy, Chien, A. Jo, Forero-Torres, Andres, Isaacs, Claudine, Nanda, Rita, Tripathy, Debu, Rodriguez, Angel, Sethi, Himanshu, Aleshin, Alexey, Rabinowitz, Matthew, Perlmutter, Jane, Symmans, W. Fraser, Yee, Douglas, Hylton, Nola M., Esserman, Laura J., DeMichele, Angela M., Rugo, Hope S., van ’t Veer, Laura J.
Published in Cancer cell (12.06.2023)
Published in Cancer cell (12.06.2023)
Get full text
Journal Article
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older
Forero-Torres, Andres, Holkova, Beata, Goldschmidt, Jerome, Chen, Robert, Olsen, Gregg, Boccia, Ralph V., Bordoni, Rodolfo E., Friedberg, Jonathan W., Sharman, Jeff P., Palanca-Wessels, Maria Corinna, Wang, Yinghui, Yasenchak, Christopher A.
Published in Blood (24.12.2015)
Published in Blood (24.12.2015)
Get full text
Journal Article